Successful, we will replay to you quickly.

OK

Your message is being sent, please wait.

Close

test

Close

Send mail failed, please send again!

Close

Products are for research use only. Not for human use. We do not sell to patients.

Signaling Pathway

ADL-5859

HY-13044

(ADL5859; ADL 5859)

ADL-5859
ADL-5859 Chemical Structure

ADL5859 is a δ-opioid receptor agonist with Ki of 0.8 nM, selectivity against opioid receptor κ, μ, and weak inhibitory activity at the hERG channel.

Price and Availability of ADL-5859
We offer a substantial discount on larger orders. Inquiry for price and availability only. Please place your order via our email or fax.
Inquiry Online Contact Us Free Sample
ADL-5859 Data Sheet

View current batch:

Purity: 99.69%

ADL-5859

Related Products

PDF File 1.64MB

Recommended Products

MORE

Biological Activity of ADL-5859

ADL5859 is a δ-opioid receptor agonist with Ki of 0.8 nM, selectivity against opioid receptor κ, μ, and weak inhibitory activity at the hERG channel.
IC50 value: 0.8 nM(Ki)
Target: δ-opioid receptor
ADL-5859 (ADL5859) is an δ-opioid receptor agonist (Ki=0.84 nM, EC50=20 nM). ADL-5859 (ADL5859)  is an agonist agent that selectively stimulates the δ-opioid receptor with potential application in a wide range of inflammatory, neuropathic and acute pain conditions. In addition, Delta agonists are thought to modulate other biological processes that may manifest themselves in disease states or conditions such as overactive bladder and depression.ADL-5859  (ADL5859)  is useful for inflammatory, neuropathic and acute pain conditions.

Clinical Information of ADL-5859

MORE

[1]. Le Bourdonnec B et al. Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859) J Med Chem. 2008 Oct 9;51(19):5893-6.
[2]. Nozaki C, et al. δ-Opioid Mechanisms for ADL5747 and ADL5859 Effects in Mice: Analgesia, Locomotion, and Receptor Internalization.J Pharmacol Exp Ther. 2012 Sep;342(3):799-807. Epub 2012 Jun 13.
[3]. Le Bourdonnec B, et al. Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).J Med Chem. 2009 Sep 24;52(18):5685-702.
[4]. Le Bourdonnec B, Windh RT, Ajello CW, Leister LK, Gu M, Chu GH, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Christ DD, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE. Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859).J Med Chem. 2008 Oct 9;51(19):5893-6. Epub 2008 Sep 13.

Products are for research use only. Not for human use. We do not sell to patients.

Keywords: buy ADL-5859 | ADL-5859 Supplier | purchase ADL-5859 | ADL-5859 cost | ADL-5859 manufacturer | order ADL-5859 | ADL-5859 distributor | ADL-5859 structure buy 850173-95-4 | 850173-95-4 Supplier | purchase 850173-95-4 | 850173-95-4 cost | 850173-95-4 manufacturer | order 850173-95-4 | 850173-95-4 distributor | 850173-95-4 structure